ES2144357A1 - Procedimiento para la obtencion del analogo de somatostatina octreotide. - Google Patents

Procedimiento para la obtencion del analogo de somatostatina octreotide.

Info

Publication number
ES2144357A1
ES2144357A1 ES009800162A ES9800162A ES2144357A1 ES 2144357 A1 ES2144357 A1 ES 2144357A1 ES 009800162 A ES009800162 A ES 009800162A ES 9800162 A ES9800162 A ES 9800162A ES 2144357 A1 ES2144357 A1 ES 2144357A1
Authority
ES
Spain
Prior art keywords
octreotide
peptide
procedure
obtaining
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009800162A
Other languages
English (en)
Other versions
ES2144357B1 (es
Inventor
Obiols Berta Ponsati
Farres Gemma Jodas
Poblet Marc Canas
Rodriguez Francisco J Clemente
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BCN Peptides SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA filed Critical Lipotec SA
Priority to ES009800162A priority Critical patent/ES2144357B1/es
Priority to ES99500012T priority patent/ES2217717T3/es
Priority to DE69915160T priority patent/DE69915160T2/de
Priority to EP99500012A priority patent/EP0953577B1/en
Priority to US09/240,145 priority patent/US6346601B1/en
Publication of ES2144357A1 publication Critical patent/ES2144357A1/es
Application granted granted Critical
Publication of ES2144357B1 publication Critical patent/ES2144357B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procedimiento para la obtención del análogo de somatostatina octreotide por medio de síntesis en fase sólida sobre soportes poliméricos y por intervención de grupos protectores del tipo Fmoc/tBu. Comprende construir el péptido lineal de 7 aminoácidos Boc-D-Phe-Cys(Trt)-Phe-D- Trp-Lys(Boc)Thr(tBu)-Cys(Trt)-Cl-tritil-R en donde R es un polímero; tratar con ácido la peptidil-resina resultante, para el desanclaje del péptido de la resina; ciclar la estructuras lineal obtenida por reacción con yodo antes o después de la incorporación en el extremo carboxi terminal del residuo de treoninol; incorporar el residuo de treoninol en solución sobre el péptido de 7 aminoácidos protegido con o sin el disulfuro formado; y desproteger las cadenas laterales con ácido para obtener octreotide.
ES009800162A 1998-01-29 1998-01-29 Procedimiento para la obtencion del analogo de somatostatina octreotide. Expired - Lifetime ES2144357B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES009800162A ES2144357B1 (es) 1998-01-29 1998-01-29 Procedimiento para la obtencion del analogo de somatostatina octreotide.
ES99500012T ES2217717T3 (es) 1998-01-29 1999-01-27 Procedimiento para la obtencion del analogo de somatostatina octreotide.
DE69915160T DE69915160T2 (de) 1998-01-29 1999-01-27 Verfahren zur Herstellung des Somatostatin Analogons Octreotide
EP99500012A EP0953577B1 (en) 1998-01-29 1999-01-27 Procedure for obtaining the somatostatin analog, octreotide
US09/240,145 US6346601B1 (en) 1998-01-29 1999-01-29 Procedure for obtaining the somatostatin analog, octreotide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009800162A ES2144357B1 (es) 1998-01-29 1998-01-29 Procedimiento para la obtencion del analogo de somatostatina octreotide.

Publications (2)

Publication Number Publication Date
ES2144357A1 true ES2144357A1 (es) 2000-06-01
ES2144357B1 ES2144357B1 (es) 2000-12-16

Family

ID=8302556

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009800162A Expired - Lifetime ES2144357B1 (es) 1998-01-29 1998-01-29 Procedimiento para la obtencion del analogo de somatostatina octreotide.
ES99500012T Expired - Lifetime ES2217717T3 (es) 1998-01-29 1999-01-27 Procedimiento para la obtencion del analogo de somatostatina octreotide.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99500012T Expired - Lifetime ES2217717T3 (es) 1998-01-29 1999-01-27 Procedimiento para la obtencion del analogo de somatostatina octreotide.

Country Status (4)

Country Link
US (1) US6346601B1 (es)
EP (1) EP0953577B1 (es)
DE (1) DE69915160T2 (es)
ES (2) ES2144357B1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476186B1 (en) * 2000-05-23 2002-11-05 Institute Of Nuclear Energy Research Process for preparing octreotide and derivatives thereof
RU2196144C1 (ru) * 2001-05-14 2003-01-10 Самуков Владимир Васильевич Защищенные производные октреотида
AU2002359359A1 (en) * 2001-12-28 2003-07-24 Somatocor Pharmaceuticals, Inc. Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
JP4615221B2 (ja) * 2002-02-27 2011-01-19 フェリング ベスローテン フェンノートシャップ ヘプタペプチドオキシトシンアナログを製造するための中間体及び方法
US6987167B2 (en) 2002-05-22 2006-01-17 Wockhardt Limited Process for production of the somatostatin analog, octreotide
CN100338090C (zh) * 2002-12-17 2007-09-19 常州市第四制药厂有限公司 生长抑素全合成新方法
DE602004001727T2 (de) * 2003-04-07 2007-08-02 Novetide Ltd. Verfahren zur herstellung cyclischer peptide
CA2458084A1 (en) * 2004-03-12 2005-09-12 Dalton Chemical Laboratories Inc. Novel process for octreotide synthesis
KR100998175B1 (ko) 2008-05-30 2010-12-03 애니젠 주식회사 소마토스타틴의 제조방법
TWI394585B (zh) * 2008-07-25 2013-05-01 行政院原子能委員會核能研究所 The magnetic fluid used for the development or treatment of peptides
WO2010089757A2 (en) 2008-11-07 2010-08-12 Usv Limited An improved process for synthesis of cyclic octapeptide
RU2435780C1 (ru) * 2010-07-08 2011-12-10 Закрытое Акционерное Общество "Фарм-Синтез" Способ получения циклического пептида - октреотида
WO2013046233A2 (en) 2011-09-30 2013-04-04 Mylan Laboratories Ltd Process for the preparation of octreotide acetate
WO2013132505A1 (en) 2012-03-09 2013-09-12 Natco Pharma Limited Improved process for preparation of octreotide by solution phase peptide synthesis
CN112500450A (zh) * 2019-09-16 2021-03-16 翰宇药业（武汉）有限公司 一种奥曲肽的合成方法
CN112778400A (zh) * 2021-02-05 2021-05-11 合肥科生景肽生物科技有限公司 一种奥曲肽的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3062075D1 (en) 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
EP0824103A1 (en) * 1996-08-13 1998-02-18 Chang-Shinn Su Method for synthesis of Tyr-3-octreotide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EDWARDS, W.B. et al. "Generally applicable convenient solid-phase synthesis and receptor affinities of octreotide analogs". J. MED. CHEM., Vol. 37, 1994, paginas 3749-3757 *

Also Published As

Publication number Publication date
EP0953577A1 (en) 1999-11-03
DE69915160D1 (de) 2004-04-08
ES2217717T3 (es) 2004-11-01
DE69915160T2 (de) 2005-01-20
EP0953577B1 (en) 2004-03-03
ES2144357B1 (es) 2000-12-16
US6346601B1 (en) 2002-02-12

Similar Documents

Publication Publication Date Title
ES2144357B1 (es) Procedimiento para la obtencion del analogo de somatostatina octreotide.
BR9007921A (pt) Sequencia de dna codificando para um derivado de fator viii humano,recombinante biologicamente ativo,vetor de expressao recombinante,cellula haspedeira de origem animal,processo para a fabricacao de um derivado e derivado de fator viii humano
US9475837B2 (en) Process for the synthesis of therapeutic peptides
ES2237356T1 (es) Procedimiento para la preparacion de peptidos ciclicos.
Green et al. Application of the NG-(2, 2, 5, 7, 8-pentamethylchroman-6-sulphonyl) derivative of FMOC-arginine to peptide synthesis
DE69827262D1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
KR850000469A (ko) hp GRF(소마토크리닌)의 합성방법
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
ES2578798T3 (es) Método de ligación nativa
ATE245168T1 (de) Peptide, die anti-zellanhaftungsaktivität aufweisen
DE60313970D1 (de) Lineare kationische peptide mit fungizider wirksamkeit
GB1508681A (en) Synthesis of peptides
ES2115543A1 (es) Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.
ATE430760T1 (de) Dipeptide und tripeptide mit anti- inflammatorischer wirkung
CO5090903A1 (es) Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
US20100204449A1 (en) Methods and intermediates for chemical synthesis of polypeptides and proteins
EP2195329A2 (en) Methods and intermediates for chemical synthesis of polypeptides and proteins
DE69831584D1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
US12624002B2 (en) Dimers for use in synthesis of peptidomimetics
EGGLESTONE et al. Peptide Synthesis
Yang et al. Design and synthesis of salmon calcitonin analogs
RU2002124640A (ru) Способ получения тридекапептида и пентапептид для его получения

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000601

Kind code of ref document: A1

Effective date: 20000601

PC2A Transfer of patent

Owner name: BCN PEPTIDES, S.A.

Effective date: 20120905